Ctc Alternative Strategies, Ltd. Bristol Myers Squibb CO Transaction History
Ctc Alternative Strategies, Ltd.
- $114 Billion
- Q2 2025
A detailed history of Ctc Alternative Strategies, Ltd. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ctc Alternative Strategies, Ltd. holds 5,700 shares of BMY stock, worth $266,817. This represents 0.23% of its overall portfolio holdings.
Number of Shares
5,700
Previous 10,200
44.12%
Holding current value
$266,817
Previous $622 Million
57.59%
% of portfolio
0.23%
Previous 0.76%
Shares
3 transactions
Others Institutions Holding BMY
# of Institutions
2,680Shares Held
1.58BCall Options Held
28.2MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...